Consistent, defined and scalable human iPSC-derived disease models for Alzheimer's disease research and drug discovery
Powered by opti-ox
Powered by opti-ox
Alzheimer's disease, the most common type of dementia, is a neurodegenerative disorder that progressively undermines patients' cognitive abilities, impairing their capacity to create and retrieve memories. Studying Alzheimer’s disease remains a significant challenge, in part because of difficulties accurately emulating the disease's pathophysiology in vitro.
There is a pressing need for an in vitro model of Alzheimer's disease that can be used to accurately and reliably study the effect of disease-associated mutations, disease progression and to identify potential therapeutic targets. ioDisease Model Cells provide scientists with defined, consistent and scalable human iPSC-derived cells engineered with common monogenic Alzheimer’s disease-related mutations, helping improve the translatability of in vitro research.
Discover ioDisease Model Cells for modelling Alzheimer’s disease in vitro below.
Generate any knockout mutation related to Alzheimer's disease with ioCRISPR-Ready Cells. These cells have Cas9 constitutively expressed, enabling scientists to easily knockout their gene of interest in physiologically relevant cells in a matter of days.
Access our platform to generate custom ioCells to precisely answer your drug discovery and disease research questions.